Submitted by Anonymous (not verified) on 8 October 2025 - 14:25
Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 19, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Gazyvaro, obinutuzumab, Date of authorisation: 22/07/2014, Revision: 19, Status: Authorised